Augmenting recombinant antibody production in HEK293E cells: optimizing transfection and culture parameters.

Antib Ther · 2022 · PMC8825235 · PMID 35146331

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

The one-way ANOVA showed no significant differences ( p > 0.05) in Pertuzumab light chain production across the seeding densities tested despite a decreasing trend above 6 × 10 5 cells/mL, where production at 10 × 10 5 cells/mL was only 41% (70 μg/mL) that of the control (177 μg/mL).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.